Cipla Sustainability
Sustainability
Our approach to responsible resource consumption, efforts to enhance access and affordability of medicines worldwide and strong financial growth, provide a robust foundation to build a responsible business.


8% Revenue CAGR over the last 5years
5.2% R&D Investment


₹ 21,763 Crores Revenue from Operations


Manufacturing Highlights
Our investments in manufacturing capital include development of new drug delivery systems, facilitation of infrastructure supporting API and formulation developments and strengthening of platform technologies.


COMMITTEES
OF BOARD
Learn MoreOF BOARD

MILESTONE
AWARDS
Learn MoreAWARDS